Literature DB >> 29950712

Ebola outbreak prompts experimental drug rollout.

Asher Mullard.   

Abstract

Entities:  

Year:  2018        PMID： 29950712     DOI： 10.1038/nrd.2018.114

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  6 in total

1.  Development of coumarine derivatives as potent anti-filovirus entry inhibitors targeting viral glycoprotein.

Authors:  Yinyi Gao; Han Cheng; Sameer Khan; Gaokeng Xiao; Lijun Rong; Chuan Bai
Journal:  Eur J Med Chem       Date:  2020-07-12       Impact factor: 6.514

Review 2.  Modalities and Mechanisms of Treatment for Coronavirus Disease 2019.

Authors:  Zhihong Zuo; Ting Wu; Liangyu Pan; Chenzhe Zuo; Yingchuo Hu; Xuan Luo; Liping Jiang; Zanxian Xia; Xiaojuan Xiao; Jing Liu; Mao Ye; Meichun Deng
Journal:  Front Pharmacol       Date:  2021-02-08       Impact factor: 5.810

Review 3.  Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19.

Authors:  Jiansheng Huang; Wenliang Song; Hui Huang; Quancai Sun
Journal:  J Clin Med       Date:  2020-04-15       Impact factor: 4.241

Review 4.  Safety perspectives on presently considered drugs for the treatment of COVID-19.

Authors:  Sophie L Penman; Robyn T Kiy; Rebecca L Jensen; Christopher Beoku-Betts; Ana Alfirevic; David Back; Saye H Khoo; Andrew Owen; Munir Pirmohamed; B Kevin Park; Xiaoli Meng; Christopher E Goldring; Amy E Chadwick
Journal:  Br J Pharmacol       Date:  2020-08-13       Impact factor: 8.739

5.  BA-12 Inhibits Angiogenesis via Glutathione Metabolism Activation.

Authors:  Herong Cui; Wenbo Guo; Beibei Zhang; Guoping Li; Tong Li; Yanyan Yuan; Na Zhang; Yuwei Yang; Wuwen Feng; Fuhao Chu; Shenglan Wang; Bing Xu; Penglong Wang; Haimin Lei
Journal:  Int J Mol Sci       Date:  2019-08-20       Impact factor: 5.923

Review 6.  Potential compounds from several Indonesian plants to prevent SARS-CoV-2 infection: A mini-review of SARS-CoV-2 therapeutic targets.

Authors:  Didi Nurhadi Illian; Etti Sartina Siregar; Sumaiyah Sumaiyah; Ahmad Rusdan Utomo; Arif Nuryawan; Mohammad Basyuni
Journal:  Heliyon       Date:  2021-01-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.